Genius PillBox Study

NCT06901258 | Completed

• 1 other identifier: STU00223484
• Study Type: interventional
• Target: 12
• Locations: 1 country
• Sites: 1

Brief Summary

The purpose of this study is to pilot test the how acceptable older adults find a commercially available pillbox organizer with embedded sensors and automated reminders to support medication adherence.

Conditions

Older Adults (65 Years and Older)

Outcome Measures

Primary Outcomes (2)

• Acceptability of Pillbox

  Acceptability Questionnaire, scores range from 9-36, higher scores indicate greater acceptability.

  1 Month

• Fidelity of Pillbox Use

  Individual items to assess use of pillbox over 30-day period. 3 items will quantify the degree and extent which the participant used the pillbox over the past 30 day.

  1 Month

Secondary Outcomes (2)

• Medication Adherence

  Baseline, 1 Month

• Medication Adherence

  Baseline, 1 Month

Study Arms (1)

Genius Pillbox

EXPERIMENTAL

Participants receive Genius Pillbox to use for 1 month

Behavioral: Genius Pillbox

Interventions

Genius Pillbox BEHAVIORAL

Participants will be mailed a Genius Pillbox to their home address. Along with the pillbox, they will also receive a detailed written description to orient them to the Genius Pillbox. Participants will be expected to use the Genius pill box organizer daily for four weeks as part of their usual medication routine. Participants are also expected to fill the designated compartments with their daily pills.

Genius Pillbox

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Age 60 or older
• Taking 3 or more medications
• Takes medications twice per day or less
• Adequate cognitive capacity (defined as less than 2 errors on 6 item cognitive screener).
• Additionally, a family member that assists with a participant's medicines can also be invited to participate. The family member eligibility criteria is:
• Age 18 or older
• Support family member taking 3 or medications, twice a day or less
• Adequate cognitive capacity (defined as less than 2 errors on 6 item cognitive screener)

Sponsors & Collaborators

• Northwestern University: lead

Study Sites (1)

Northwestern University

Chicago, Illinois, 60611, United States

Location

Study Officials

• Rachel O'Conor, PhD, MPH

  Northwestern University

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: HEALTH SERVICES RESEARCH
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Assistant Professor

Study Record Dates

• First Submitted: March 17, 2025
• First Posted: March 28, 2025
• Study Start: March 31, 2025
• Primary Completion: May 23, 2025
• Study Completion: May 23, 2025
• Last Updated: April 15, 2026

Record last verified: 2026-04

Data Sharing

• IPD Sharing: Will not share

Locations

US (1)